Making good time: The Tipline for 4 March 2019
Happy Monday! The Federal Trade Commission and Department of Justice have discussed the benefits of their new model timing agreements, the Actavis litigation has officially closed, and the House of Representatives’ antitrust subcommittee is set to take a closer look at the pharmaceutical industry in its first hearing under Democratic leadership.
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10